 Ling Lu
Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 3 | 2022 | 604 | 0.340 |
Why?
| | Diphtheria Toxin | 2 | 2022 | 66 | 0.220 |
Why?
| | Interleukin-2 | 1 | 2022 | 455 | 0.180 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 175 | 0.170 |
Why?
| | Pyridazines | 1 | 2019 | 56 | 0.160 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 95 | 0.150 |
Why?
| | Imidazoles | 1 | 2019 | 238 | 0.150 |
Why?
| | Smad4 Protein | 1 | 2018 | 38 | 0.150 |
Why?
| | Salivary Gland Neoplasms | 1 | 2018 | 41 | 0.140 |
Why?
| | PTEN Phosphohydrolase | 1 | 2018 | 162 | 0.130 |
Why?
| | Saliva | 1 | 2018 | 242 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 399 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 1058 | 0.100 |
Why?
| | DNA Methylation | 1 | 2018 | 640 | 0.100 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 3405 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 692 | 0.090 |
Why?
| | Signal Transduction | 2 | 2019 | 5075 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 868 | 0.070 |
Why?
| | Protein Kinase Inhibitors | 2 | 2021 | 916 | 0.050 |
Why?
| | Mice | 4 | 2022 | 17733 | 0.050 |
Why?
| | Erlotinib Hydrochloride | 1 | 2021 | 72 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 366 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2022 | 613 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 600 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 327 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 672 | 0.040 |
Why?
| | Mifepristone | 1 | 2018 | 64 | 0.040 |
Why?
| | Carcinoma, Adenoid Cystic | 1 | 2018 | 17 | 0.040 |
Why?
| | Salivary Glands | 1 | 2018 | 33 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2021 | 664 | 0.040 |
Why?
| | Animals | 4 | 2022 | 36823 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 5735 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2019 | 209 | 0.030 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2019 | 234 | 0.030 |
Why?
| | Area Under Curve | 1 | 2018 | 314 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 622 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 843 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 366 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2018 | 480 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2018 | 412 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1249 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 657 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 2067 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2472 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1272 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2750 | 0.020 |
Why?
| | Humans | 5 | 2022 | 136764 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2122 | 0.020 |
Why?
| | Aged | 1 | 2018 | 23794 | 0.010 |
Why?
| | Middle Aged | 1 | 2018 | 33228 | 0.010 |
Why?
| | Adult | 1 | 2018 | 37630 | 0.010 |
Why?
| | Male | 1 | 2018 | 67309 | 0.010 |
Why?
| | Female | 1 | 2018 | 72787 | 0.010 |
Why?
|
|
Lu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|